by Paul Winner | Nov 27, 2016 | Alzheimer's Disease
A form of gene therapy has yielded positive findings in the search for a potential cure to Alzheimer’s disease, according to research published from the journal Proceedings of the National Academy of Sciences. Researchers in the United Kingdom from Imperial College...
by Paul Winner | Nov 21, 2016 | Alzheimer's Disease
The risk factors for Alzheimer’s disease are non-modifiable, physiological, and behavioral. Non-modifiable risk factors include age, which is the most prominent risk factor for Alzheimer’s disease. At 65 years of age, our chances of getting Alzheimer’s disease...
by Paul Winner | Nov 20, 2016 | Migraines
A study conducted by researchers from the Cincinnati Children’s Hospital Medical Center found that many young migraine sufferers also have multiple vitamin deficiencies. Low levels of vitamin D, coenzyme Q10 and riboflavin were seen in many migraine patients at the...
by Paul Winner | Nov 15, 2016 | Alzheimer's Disease
According to new research, inflammation brain changes related to Alzheimer’s disease may begin as early as 20 years before symptoms develop. This discovery has significant implications for prevention of the disease, since addressing the inflammation earlier in life...
by Paul Winner | Nov 9, 2016 | Alzheimer's Disease
Overview: Alzheimer’s disease is a chronic, degenerative and progressive disease of the brain characterized by a loss of neurons and synapses and is currently ranked as the 7th leading cause of death in the United States. According to the Alzheimer’s Association, an...
